Vericel Corporation share price logo

Vericel Corporation

NASDAQ: VCEL

Small Cap

$38.46

+0.17

(+0.44%)

as on

Vericel Corporation Stock Performance

as on June 17, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $38.15
    $39.00
    downward going graph

    0.81%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $28.95
    $43.57
    downward going graph

    24.73%

    Downside

    13.29%

    Upside

    downward going graph

Vericel Corporation share price movements today

Previous Close
$38.29
Open
$38.16
Volume
569.0K
Day's Low - High
$38.15 - $39.00
52 Week Low - High
$28.95 - $43.57

Vericel Corporation Historical Returns

1 Month Return
+ 16.44 %
3 Month Return
+ 18.34 %
1 Year Return
-7.33 %
3 Year Return
+ 14.23 %
5 Year Return
-36.93 %

Vericel Corporation Stock Fundamentals & Key Indicators

Check Vericel Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

0.452

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

89.05

Industry PE ratio

-3.629517543859649

PEG Ratio

0

EBITDA

27.9M

Revenue (TTM)

292.1M

Profit Margin

7.35%

Return On Equity TTM

6.59%

Vericel Corporation Stock Valuation

Track how Vericel Corporation P/E has moved over time to understand its valuation trends.

Vericel Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-173.35x)

September 30, 2023

Industry (-3.63x)

June 17, 2026

Today (89.05x)

June 17, 2026

Highest (149.61x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 89.05x

Vericel Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vericel Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Vericel Corporation image
Vericel Corporation
BUY$2.0B-36.93%89.057.35%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$38.4B63.66%72.4912.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.3B140.59%26.7335.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for Vericel Corporation Stock including INR - Dollar returns

The Vericel Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vericel Corporation investment value today

Current value as on today

₹1,02,072

Returns

₹2,072

(+2.07%)

Returns from Vericel Corporation Stock

-₹7,325 (-7.33%)

Dollar Impact

₹9,397 (+9.4%)

Analyst Recommendation on Vericel Corporation Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Vericel Corporation. Average target price of $55.43

Vericel Corporation Share Price Target

Get share price movements and forecasts by analysts on Vericel Corporation.

What analysts predicted

30.62%UPSIDE

Target Price

$55.43

Current Price

$38.46

Analyzed by

12 Analysts

Target

$55.43

Vericel Corporation target price $55.43, a slight upside of 30.62% compared to current price of $38.46. According to 12 analysts rating.

Indian Investors' Interest in Vericel Corporation Stock

Search interest for Vericel Corporation Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Vericel Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
64
51
52
57
75
52
63
67
92
68
Gross Profit
48
35
36
41
58
36
46
49
73
49
Operating Income
12
-5
-6
-2
18
-12
-2
3
22
-8
EBITDA
15
-2
-3
0
21
-8
2
8
27
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
1
2
2
2
3
3
Income Before Tax
14
-3
-4
0
19
-11
0
5
24
-6
Income Tax Expense
1
1
-
-
0
-
-
-
0
-
Net Income
12
-3
-4
0
19
-11
0
5
23
-6
Net Profit Margin
19.99%
-7.53%
-8.89%
-1.56%
26.28%
-21.38%
-0.87%
7.52%
25.01%
-9.21%

Vericel Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
54
63
90
117
124
156
164
197
237
276
Gross Profit
26
33
58
80
84
106
109
135
172
205
Operating Income
-19
-14
-3
-11
2
-7
-17
-6
4
11
EBITDA
-17
-14
-4
-7
5
-4
-11
2
16
30
Interest Expense
0
1
1
0
0
0
0
0
0
1
Depreciation
-
1
1
1
2
2
3
4
5
11
Income Before Tax
-19
-17
-8
-9
3
-7
-15
-2
10
17
Income Tax Expense
2
1
3
-1
0
0
0
0
0
0
Net Income
-19
-17
-8
-9
2
-7
-16
-3
10
16
Net Profit Margin
-35.98%
-27.04%
-8.96%
-8.20%
2.31%
-4.78%
-10.17%
-1.61%
4.37%
5.98%

Vericel Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-4
0
19
-11
0
5
23
-6
Operating Cash Flow
7
18
10
22
6
8
22
15
16
Investing Cash Flow
-25
-17
-21
-14
-15
-9
-3
-16
-4
Financing Cash Flow
2
4
5
7
3
1
1
1
-2
Change in Cash
-16
5
-5
14
-5
0
19
0
9

Vericel Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-17
-8
-9
2
-7
-16
-3
10
16
Operating Cash Flow
-13
0
-7
17
29
17
35
58
51
Investing Cash Flow
-1
-67
10
-17
-3
-36
-3
-79
-43
Financing Cash Flow
18
58
5
6
9
1
3
19
7
Change in Cash
3
-8
8
6
34
-17
35
-1
15

Global Institutional Holdings in Vericel Corporation

Funds
Holdings
State Street Corp
6.17%
Amvescap Plc.
1.46%
Conestoga Capital Advisors, LLC
4.82%
Silvercrest Asset Management Group LLC
1.88%
Vanguard Group Inc
7.02%
See all

Insights on Vericel Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VCEL has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, VCEL stock has moved up by 16.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 20.8% return, outperforming this stock by 28.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 92.91M → 68.42M (in $), with an average decrease of 26.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 23.24M → -6.30M (in $), with an average decrease of 127.1% per quarter

About Vericel Corporation

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.
OrganisationVericel Corporation
Headquarters25 Blue Sky Drive, Burlington, MA, United States, 01803
IndustryBiotechnology
CEOMr. Dominick C. Colangelo Esq.
E-voting on sharesClick here to vote

Key Management of Vericel Corporation

Name

Title

Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.

Chief Medical Officer

Mr. Jonathan D. Siegal

Principal Accounting Officer, VP & Corporate Controller

Mr. Eric Burns

Vice President of Finance & Investor Relations

Mr. Patrick J. Fowler

Senior Vice President of Corporate Development & Strategy

Mr. Dominick C. Colangelo Esq.

CEO, President & Director

Mr. Joseph Anthony Mara Jr.

CFO & Treasurer

Mr. Michael Halpin

Chief Operating Officer

Mr. Sean C. Flynn

Chief Legal Officer

Mr. Roland DeAngelis

Chief Marketing Officer

Mr. Mike Gilligan

Senior Vice President of Sales

FAQs

What is Vericel Corporation share price today?

Vericel Corporation share price today is $38.46 as on at the close of the market. Vericel Corporation share today touched a day high of $39 and a low of $38.15.

What is the 52 week high and 52 week low for Vericel Corporation share?

Vericel Corporation share touched a 52 week high of $43.57 on and a 52 week low of $28.95 on . Vericel Corporation stock price today i.e. is closed at $38.46,which is 11.73% down from its 52 week high and 32.85% up from its 52 week low.

What is Vericel Corporation's market capitalisation today?

Vericel Corporation market capitalisation is $0.00T as on .

How to invest in Vericel Corporation Stock (VCEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vericel Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vericel Corporation Shares that will get you 0.0390 shares as per Vericel Corporation share price of $38.46 per share as on June 17, 2026 at 8:45 am IST.

What is the minimum amount required to buy Vericel Corporation Stock (VCEL) from India?

Indian investors can start investing in Vericel Corporation (VCEL) shares with as little as ₹94.55 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Vericel Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Vericel Corporation share’s latest price of $38.46 as on June 17, 2026 at 8:45 am IST, you will get 0.2600 shares of Vericel Corporation. Learn more about fractional shares .

What are the returns that Vericel Corporation has given to Indian investors in the last 5 years?

Vericel Corporation stock has given -36.93% share price returns and 29.26% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?